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KAJIAN ANTIMIKROB, ANTIOKSIDAN DAN KETOKSIKAN SPESIES 
Cassia  SERTA POTENSI SEBAGAI AGEN ANTIKANDIDA 
 
ABSTRAK 
Dalam penyelidikan ini tiga Cassia spesies dikaji untuk aktiviti antimikrob, 
antioksidan dan ujian ketoksikan. Ekstrak metanol daun, bunga, batang dan lengai 
Cassia spectabilis, Cassia surattensis dan Cassia fistula telah disaring untuk aktiviti 
antimikrob melalui kaedah resapan cakera terhadap bakteria Gram positif dan Gram 
negatif, serta kulat. Keputusan menunjukkan bahawa ekstrak daun C. spectabilis 
mempunyai spektrum aktiviti antimikrob yang luas oleh itu ekstrak ini dipilih untuk 
menentukan Kepekatan Perencatan Minimum (MIC) dan kajian lanjutan secara 
mendalam untuk aktiviti antikandida. Nilai MIC terhadap bakteria Gram-positif dan 
Gram-negatif adalah dalam julat 0.195 hingga 50 mg/mL. Bagi aktiviti antikandida, 
ekstrak daun menunjukkan aktiviti yang baik terhadap Candida albicans dengan 
nilai MIC 6.25 mg/mL. Kesan ekstrak daun terhadap profil pertumbuhan C. albicans 
menunjukkan ekstrak telah mengubah pertumbuhan normal yis tersebut maka 
mengesahkan aktiviti antikandida terhadap C. albicans. Sel C. albicans yang dirawat 
dengan ekstrak daun menunjukkan pengurangan pembentukan biofilem disebabkan 
oleh kesan tindakan ekstrak. Pengimejan SEM dan TEM untuk menentukan 
perubahan drastik pada mikrostruktur dalaman dan luaran sel C. albicans 
menunjukkan perubahan abnormal yang ketara. Perubahan morfologi dan 
pemecahan sel yis secara meyeluruh dapat diperhatikan selepas 36 jam pendedahan 
terhadap ekstrak daun. Penyaringan fitokimia ekstrak daun C. spectabilis melalui 
kaedah analisis GC-MS menunjukkan kehadiran asid asetik dan digliserol yang 
xviii 
 
mana telah dilaporkan sebagai agen antimikrob. Aktiviti antioksidan melalui ujian 
DPPH terhadap ekstrak bunga C. surattensis menunjukkan aktiviti yang menyerlah 
dengan nilai RSA 93.54% dan nilai IC50 423.3 µg/mL. Tambahan pula, ekstrak 
bunga tersebut mempunyai kandungan fenol yang tinggi, 657.24 mg GAE/g ekstrak 
jika dibandingkan dengan bahagian tumbuhan lain. C. surattensis telah dikaji secara 
mendalam untuk aktiviti perencatan xanthine oksidase dan didapati ekstrak bunga C. 
surattensis menunjukkan aktiviti perencatan yang tinggi terhadap xanthine oxidase 
dengan nilai perencatan sebanyak 76.8% dan nilai IC50 sebanyak 11.3 µg/mL. Ujian 
ketoksikan anak udang brin dengan ekstrak daun C. spectabilis tidak menunjukkan 
kesan toksik yang signifikan dengan nilai LC50 2.20 mg/mL. Tambahan pula, kajian 
ketoksikan akut oral in vivo terhadap tikus juga menunjukkan tidak toksik dengan 
nilai LD50 lebih dari 2000 mg/kg berat badan. Tiada sebarang kesan atau simptom 
toksik pada mencit yang dirawat berbanding dengan tikus kawalan. Pemerhatian 
histopatologi menyokong keputusan ini, dimana tiada perubahan besar diperhatikan 
pada ginjal, hati, paru-paru dan limpa. Secara keseluruhan keputusan yang didapati 
mencadangkan ekstrak daun C. spectabilis sebagai pilihan terbaik untuk 
menghasilkan agen antikandida yang baru dari pada sumber alam. Di samping itu, 
ekstrak bunga C. surattensis kemungkinan besar boleh menyumbang sebagai sumber 
antioksidan semulajadi pada masa hadapan. 
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ANTIMICROBIAL, ANTIOXIDANT AND TOXICITY STUDIES OF Cassia 
SPECIES AND THE POTENTIAL AS ANTICANDIDAL AGENT 
 
ABSTRACT 
In this study three Cassia species were subjected to antimicrobial, 
antioxidant and toxicity studies. Methanol extracts of the leaf, flower, stem and pod 
of Cassia spectabilis, Cassia surattensis and Cassia fistula were screened for 
antimicrobial activity by disc diffusion assay against Gram-positive and Gram-
negative bacteria, and fungi. It was found that the leaf extract of C. spectabilis 
possessed a broad-spectrum of antimicrobial properties, hence this extract was 
evaluated to determine the Minimum Inhibitory Concentration (MIC) and further 
detailed to anticandidal activity study. The MIC values against the Gram-positive 
and Gram-negative bacteria ranged from 0.195 to 50 mg/mL for the extract. In the 
anticandidal activity study, the leaf extract showed a favorable activity against 
Candida albicans with MIC value of 6.25 mg/mL. The effect of the leaf extract on 
growth profile of C. albicans was examined and results revealed that the extract 
altered the normal growth of the yeast thus confirming the anticandidal effect on C. 
albicans. The treated cells of C. albicans by the leaf extract revealed that the biofilm 
formations have decreased. Imaging using SEM and TEM to determine the major 
alteration on the microstructure of the outer and inner cells of C. albicans showed 
distinct main abnormalities. Alterations in morphology and complete collapse of 
yeast cells were observed after 36 hours of exposure to the leaf extract. 
Phytochemical screening of the leaf extract of C. spectabilis by GC-MS analysis, 
showed presence of acetic acid and diglyserol which were reported as antimicrobial 
xx 
 
agents. Antioxidant activity of C. surattensis flower extract via DPPH assay 
revealed a remarkable scavenging activity with RSA value of 93.54% and IC50 value 
of 423.3 µg/mL. In addition, the flower extract also possessed a higher phenolic 
content 657.24 mg GAE/g extract compared with other parts of the plant. C. 
surattensis extracts were further evaluated for the xanthine oxidase inhibitory assay. 
Results showed that the flower extract of C. surattenisis exhibited a high inhibitory 
activity of xanthine oxidase with value of 76.8% and IC50 value of 11.3 µg/mL. The 
brine shrimp toxicity assay of C. spectabilis leaf extract showed no significant 
toxicity with LC50 value of 2.20 mg/mL. Furthermore, the in vivo oral acute toxicity 
study in mice also revealed that the leaf extract showed no toxicity with LD50 value 
greater than 2000 mg/kg body weight. There were no toxic signs or symptoms on 
the treated mice compared with control. Histopathological examinations supported 
this finding where there were no major alterations observed in the kidney, liver, 
lungs and spleen. In conclusion, the obtained results suggested that the C. spectabilis 
leaf extract as an excellent candidate to develop a new anticandidal agent from 
nature. Additionally, C. surattensis flower may highly provide as a natural source of 
antioxidant agent in future. 
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CHAPTER ONE 
INTRODUCTION 
In the pre-antibiotic era, a major determinant of human morbidity and 
mortality are infectious diseases. Today multidrug resistant organisms are costly to 
treat and the treatments which are done most of the times are prone to failure. These 
pathogens are resistant to multiple antimicrobial classes which cover most or 
sometimes all the antimicrobials in clinical usage (Deshpande et al., 2004; D'Agata, 
2004). The conventional view of antibiotic resistant is one where microorganisms 
exhibit significantly reduced susceptibility to antimicrobials in laboratory tests by 
mechanisms such as altered drug uptake, altered drug target and drug inactivation. 
Unfortunately, a different scenario typically prevails in the clinic where treatment 
fails in spite of antibiotic sensitivity in laboratory tests. In other words, clinical 
failure is often due not to infections with microorganisms harboring mechanisms 
resulting in high level antibiotic resistance, but rather to organisms that are 
phenotypically resistant in vivo. 
An example of phenotypically resistant in vivo is the biofilm growth which 
almost always leads to a significant decrease in susceptibility to antimicrobial agents 
compared with cultures grown in suspension. To be precise, when biofilm 
microorganisms are grown in conventional laboratory suspension culture they 
become susceptible to antimicrobials (Poole et al., 2005). A number of elements in 
the process of biofilm formation have been studied as targets for novel drug delivery 
technologies. These include, surface modification of devices to reduce 
microorganisms attachment and biofilm development as well as incorporation of 
antimicrobials agent to prevent colonisation (Smith, 2005). One of an example of 
biofilm associated microorganism is the C. albicans. It causes infection in its biofilm 
2 
 
mode of growth and has gain attention with an increasing recognition of resistant to 
phenotypic adaptation within the biofilm (Jain et al., 2007). 
During the past several years, there have been increasing incidences of 
fungal infections by C. albicans due to a growth in immunocompromised population 
such as organ transplant recipients, cancer, and HIV or AIDS patients. This fact 
coupled with the resistance to antibiotics and with the toxicity during prolonged 
treatment with several antifungal drugs (Giordani et al., 2001; Fostel and Lartey, 
2000) have been the reasons for an extended search for newer drugs to treat 
opportunistic fungal infections. Studies of AIDS all over the world show that 58 to 
81% of all patients contract a fungal infection and also at some time during the 
primordial stage or after developing AIDS. In addition, 10 to 20% have died as a 
direct consequence of fungal infections (Motsei et al., 2003). 
 In HIV patients, the presence of oral candidiasis is the earliest opportunist 
infection (Fan-Havard et al., 1991). Clinically, the fungal infection is identified as 
creamy-white, curd-like patches on the tongue or other oral mucosal surfaces which 
are removed by scrapings. If left untreated, this leads to difficulty in chewing and 
swallowing and is sometimes associated with severe diarrhoea (Dube and Mutloane, 
2001). Hence, those who suffer from oral Candida often lose a lot of weight because 
of a sore throat, which prevents them from eating (Sanne, 2001). C. albicans is the 
most frequent etiological agent associated with this oral infection (Patel and Coogan, 
2008). Other related diseases caused by C. albicans are genital candidasis (Sobel, 
2005), inflammatory lesions in muscular and soft tissues (Ruiz-Cabello et al., 1999), 
and lung infection (Goldenberg and Price, 2008). 
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In the past the wide range of antimicrobial agents from lower organisms and 
synthetic drugs sufficed in the treatment or control of infectious diseases. However, 
the microbial drug resistance and the increase of opportunistic infections especially 
with AIDS patients and individuals on immunosuppressive chemotherapy currently 
change the whole scenario. Many antifungals are of limited use due to toxicity, 
while other infectious diseases have not yet found a cure. These problems pose a 
need for searching more new substances from other sources especially plants 
(Cowan, 1999). Natural products, either as pure compounds or as standardized plant 
extracts, provide unlimited opportunities for new drug discovery because of the 
unmatched availability of chemical diversity (Cos et al., 2006). According to the 
World Health Organization (WHO), about three quarter of the world population 
depends on traditional remedies for their health care (Gilani and Rahman, 2005).  
The international market of herbal for herbal medicine is more than $ 60 
billion a year and growing at the rate of 7 % annually. It is believed that the world 
demand for herbal medicine is likely to rise to $ 3 trillion by the year 2050 from the 
existing level. However, the past few years have seen a major increase in their use in 
the developed world. In Germany and France, many herbs and herbal extract are 
used as drugs prescription and their sales in the countries of European Union were 
around $ 6 billion in 1991 and may be over $ 20 billion now. In USA herbal drugs 
are currently sold in health food store with a turnover of about $ 4 billion in 1996 
(Rawls, 1996). In India the herbal drug market is about $ 1 billion and the export of 
plants based crude drug is around $ 80 million. Herbal medicine also find market as 
nutraceuticals or „health food‟ where sales have reached about $ 60 billion globally 
and $ 20 billion in the USA in 2004, experiencing all average annual growth rate of 
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approximately 4% since 2000 (Saivaino, 2006). All this statistical data are evidence 
for the bright future of natural product based antimicrobial development program.  
Since plants produce a variety of compounds with antimicrobial properties, it 
is expected that screening programs for some under-represented targets such as 
antifungal activity, may yield candidate compounds for developing new 
antimicrobial drugs (Ahmad and Beg, 2001). In addition, it is expected that plant 
compounds showing target sites other than those currently used by antibiotics, will 
be active against drug-resistant microbial pathogens such as C. albicans (Duarte et 
al., 2005). Yet, the information available on plants, particularly medicinal plants, 
and active against this yeast species has until recently, not resulted in effective 
formulations for humans or animal use. According to literature, the investigation of 
natural products active against Candida species increased significantly in the last 10 
years, with investigations of approximately 258 plant species from 94 families 
(Duarte and Figueira, 2005). 
Another major hitch to humans is free radicals. Free radicals are molecules 
produced when our body breaks down food, or by environmental exposures like 
tobacco smoke and radiation. However, oxygen-centered free radicals and other 
reactive oxygen species (ROS) which are continuously produced in vivo, result in 
cell death and tissue damage. Oxidative damage caused by free radicals may be 
related to aging and diseases, such as atherosclerosis, diabetes, cancer and cirrhosis 
(Halliwell and Gutteridge, 1985). Antioxidant compounds reduce the action of ROS 
in tissue damage (Lillian et al., 2007). The search of new products with 
antioxidative properties from natural resources such as medicinal plants, is a very 
active domain of research (Cengiz et al., 2008). Although humans and other 
organisms possess antioxidant defence enzymes, such as superoxide dismutase and 
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catalase, or compounds such as ascorbic acid, tocopherols and glutathione and repair 
systems to protect them against oxidative damage, these systems are insufficient in 
totally preventing the damage (Simic, 1988; Mau et al., 2002). However, antioxidant 
supplements or foods containing antioxidants, may help the human body reduce the 
oxidative damage (Yanga et al., 2002). 
Malaysia is known as one of the world‟s 12 mega-biodiversity hotspots in 
the world, where it‟s a home to an estimated 9% of the world known species (Saidin, 
1993). These statistics provide us unlimited opportunities of our country‟s natural 
resources which could be explored and investigated to develop natural product based 
antiinfectious and antioxidant agent. In Malaysia, various medicinal plants are used 
to treat diverse diseases. From approximately 250,000 higher plant species that exist 
on our planet, only 15% have been studied phytochemically and 6% have been 
screened for diverse biological activities. The genus Cassia has been used as a 
potential medicinal plant since long ago (Chopra et al., 1956; Ayo et al., 2007). 
Thus in this study, the extracts of leaf, flower, stem and pod of C. spectabilis, C. 
surattensis and C. fistula was evaluated in several distinct studies. 
The current study was undertaken with the following objectives: 
1) To obtain the optimum extract of Cassia leaf, flower, pod and stem for 
antimicrobial, antioxidant and toxicity testings. 
2) To study the in vitro and in vivo antimicrobial activity of Cassia species.  
3) To find the phytochemicals in the selected Cassia species from the 
antimicrobial studies. 
4) To study the antioxidant activity of the Cassia species. 
5) To investigate the toxicity of the selected Cassia species.  
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CHAPTER TWO 
LITERATURE REVIEW 
2.1  Antimicrobial 
2.1.1 Antimicrobial agents 
 Infectious diseases by microorganism actions daily caused about 50 thousand 
of premature deaths (Carey, 2004; Esterhuizen et al., 2006). This signifies that the 
control of microorganism is crucial in prevention and curing of diseases caused by 
their action. An antimicrobial agent is a substance that kills or inhibits the growth or 
prevents damage due to the action of infectious microorganisms. Antimicrobial 
agents comprise of antibacterial, antifungal, antiprotozoal, antihelminthic and 
antiviral agents (Baron et al., 1994). Antibacterial agents are also closely associated 
with antibiotics. Antibiotics are substances produced by bacteria and fungi that 
inhibit the growth and kill other bacteria (Purohit et al., 2003). Substances that kill 
or inhibit the growth of fungi are known as antifungal agent (McDonnell, 2007). 
Since the discovery of the antimicrobial activity of penicillin by Alexander 
Fleming, the field of antimicrobial agent or drug discovery has been largely 
dominated by whole-cell screening assay. The capability to inhibit the growth of 
actively multiplying bacteria is preferred in selecting the best antimicrobial 
compounds, although the mechanism of action of such compounds is not always 
understandable. However, this approach was successful in the early days of 
antibiotic development and still holds a good prospective for the screening of large 
synthetic chemical libraries with novel chemistries or naturally occurring 
antimicrobials, including peptides (Bax et al., 1998; Overbye and Barrett, 2005). 
Now, research of antimicrobial drug discovery has integrated a complementary 
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strategy where the potential novel targets, which are important for the survival or 
growth of bacteria, are well identified. A better understanding of the metabolism and 
the sequencing of the genes, which involved in the process, makes the identification 
of novel targets possible (Brazas and Hancock, 2005). 
Although the foundation for a whole new era in antimicrobial agent or drug 
discovery are related to bacterial genomics and its related technologies, there are still 
no new antimicrobial agents in late clinical development that have originated solely 
from genomics-based approaches (Coates et al., 2002). A few antimicrobial agents 
have recently entered into early clinical development by the attempt of several 
pharmaceutical companies using such strategies in antimicrobial drug discovery. 
However, this attempt has also resulted without a major return on the investment 
made (Bush et al., 2004). This failure in an area of research with so much 
prospective, leads one to wonder that there might be other antibacterial targets and 
modes of action left to be discovered (Coates et al., 2002). 
2.1.2 Characteristics of antimicrobial agent’s activities in vitro 
2.1.2.1 Antimicrobial activity is measurable 
An antimicrobial activity can be measured by using two growth-based 
methods; through determination of the inhibitory and the killing capabilities. When 
measuring the inhibitory activity, the results are referred as Minimum Inhibitory 
Concentration (MIC) which is a common method used in in vitro antimicrobial 
susceptibility testing. The MIC is defined as the lowest concentration of an 
antimicrobial agent that inhibits visible growth of microorganism (Andrews, 2001). 
The results generated from this method are interpreted as semi-quantitative or 
qualitative. By using the disc diffusion method, susceptibility testing could also be 
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carried out and the activity is measured relative to the size of the zone of inhibition 
around the disc embedded with an agent. In vitro susceptibility testing is normally 
performed either in clinical or veterinary laboratories. Interpretations of these in 
vitro results are based upon standards within the United States which recommended 
by the National Committee for Clinical Laboratory Standards (NCCLS, 2003).  
At the concentration equal or higher than MIC, some antimicrobials are 
lethal to bacteria while others have primarily bacteriostatic activity. The term 
bacteriostatic or bactericidal, describes an agent‟s antibacterial mode of action. The 
bactericidal effect of a particular drug can be determined in vivo, but it is not always 
tested due to technical and interpretive difficulties (Lorian, 1996; Lopes and 
Moreno, 1991). Antimicrobial killing effect can be measured by exposing microbes 
to a given concentration of drug and the reduction of the population is measured 
over time. This method is also known as „killing-curve‟ where the killing of an in 
vitro response relationship is observed. The bactericidal effect can be also measured 
in the presence of serum, where it shows the in vivo antimicrobial activity due to the 
impact of the serum components (MacGowan et al., 1997).  
2.1.2.2 Antimicrobial activity is specific 
 Antimicrobial agents act on microbes by targeting one or more specific 
components of the microbe cells that are essential for their physiological and 
replication functions. Many antimicrobial are categorised based on their mechanisms 
of action. Microorganisms that are inhibited by antimicrobial agents are target-
specific and it dependent upon the drug‟s mode of action. Nevertheless, effect 
exerted by antimicrobial drugs can be either a direct event subsequent to the 
9 
 
inhibition of the same cellular targets or cascade of reaction resulting from a 
particular drug interaction (Yan and Gilbert, 2004).  
2.1.3 Evaluation of antimicrobial activity 
By observing the growth response of various microorganisms towards 
natural extracts and pure compounds, the antimicrobial activity could be observed. A 
number of methods for detecting activity are available, but since these methods are 
not equally sensitive or not based upon the same principle, the results will be 
profoundly influenced by the methods. The antibacterial and antifungal test methods 
are classified into two main groups; agar-diffusion and dilution method. 
2.1.3.1 Agar-diffusion method 
In the agar-diffusion technique, a reservoir containing the test compound at a 
known concentration is brought into contact with an inoculated medium and the 
diameter of the clear zone around the reservoir is measured at the end of the 
incubation period. The inoculated system is kept at lower temperature for several 
hours before incubation to enhance compound diffusion over microbial growth.  
Many types of reservoirs can be used, such as filter paper discs or stainless steel 
cylinders placed on the surface and holes punched in the medium. The hole-punch 
method is only suitable for aqueous extracts, because of the interference by 
particulate matter is much less than with other types of reservoirs. However little 
sample requirements and the possibility to test up to six extracts per plate against a 
single microorganism are its specific advantages (Hadacek and Greger, 2000). For 
testing non-polar samples or samples that do not easily diffuse into agar this hole-
punch method is not appropriate. Generally, the relative antimicrobial potency of 
different samples may not always be compared. This is due to the differences in 
10 
 
physical properties, such as solubility, volatility and diffusion characteristics in agar 
(Cos et al., 2006). 
2.1.3.2 Dilution method 
In the dilution method, the test compounds are mixed with a suitable medium 
that has previously been inoculated with the test organism. This method can be 
carried out in liquid as well as in solid media. The growth of the microorganism can 
be measured in a number of ways such as the agar dilution method and liquid or 
broth dilution methods where turbidity and redox-indicators are most frequently 
used in these last two methods. Turbidity can be estimated visually or obtained more 
accurately by measuring the optical density at 405 nm. However, test samples that 
are not fully soluble may interfere with turbidity readings, emphasizing the need for 
a negative control or sterility control. As an example an extract dissolved in blank 
medium without microorganisms is referred and compared. As for the liquid dilution 
method it also allows determination whether a compound or extract has a cidal or 
static action at a particular concentration (Cos et al., 2006). 
 
2.2       Antioxidants 
Antioxidants are elements of a collection of processes that hinder in vivo free 
radical oxidation. The term antioxidation includes all of the processes that slow 
down or stop free radical oxidation. Antioxidation processes include, scavenging 
radicals to prevent their propagation and enzymatic hydrolysis of ester bonds to 
remove peroxidized fatty acids from lipids, also facilitates processes such as 
sequestration of transition metal ions, and enzyme-catalyzed reduction of peroxides. 
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The scavenging radicals that prevent propagation define how an antioxidant works. 
As for the other three processes, it does not stop the reactions of radicals. As an 
alternative, they prevent the accumulation of molecules that can enhance free radical 
reactions (Thomas, 2000).  
Antioxidants minimize radical-caused damages by reducing the energy of the 
free radical. The reduced energy prevents the free radical from forming, or 
interrupting the oxidation chain reaction itself. To control the number of free 
radicals, the body produces enzymatic scavengers called endogenous antioxidants, 
which include superoxide dismutase (SOD), glutathione peroxidase (GHS-px), and 
catalase. However, even with maximum production of endogenous antioxidants, the 
body‟s defenses can sometimes be overwhelmed. That is when exogenous 
antioxidants, such as particular vitamins, minerals and herbs may be used to aid the 
body (Greenly, 2004).  
2.2.1 Enzymatic and non-enzymatic antioxidants 
Antioxidants that react directly with radicals or other reactive species to 
prevent cellular compounds from becoming oxidized can be divided into enzymatic 
and non-enzymatic antioxidants. Enzymatic antioxidants react with reactive species 
and then efficiently recycled after the process. Examples of important antioxidant 
enzymes are superoxide dismutases, catalase and glutathione peroxidases (Diplock 
et al., 1998). As for the non-enzymatic antioxidants it can be divided into 
hydrophilic and hydrophobic antioxidants. Hydrophobic antioxidants include α- 
tocopherol (vitamin E), carotenoids, and ubiquinol are mostly detected in 
lipoproteins and membranes. Hydrophilic scavengers include glutathione (GSH), 
ascorbate and uric acid which are predominantly found in cytosolic, mitochondrial 
and nuclear aqueous compartments (Chaudiere and Ferrari-Iliou, 1999).  
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2.2.2 Free radicals 
Free radicals are defined as reactive molecules due to the presence of one or 
more unpaired electron(s). These free radicals are generated in the human body 
either as an essential mediator in vital processes including neurotransmission and 
inflammatory reactions, or as a byproduct that does not have a role in the actual 
process. Oxygen is essential to life but at the same time, it is a dangerous culprit. 
Oxygen molecules become very unstable and highly reactive when one or more 
electrons are stripped of from their outer orbits and left with unpaired electrons. In 
this oxidation process, the stripped oxygen molecules that are referred as free 
radicals, aggressively attack other stable molecules and snatch away their electrons. 
After having their electrons stolen, the formerly stable molecules then become free 
radicals themselves. In the consequent chain reaction, the cascading numbers of free 
radicals may overwhelm the body‟s defenses and impose lethal damage. Free 
radicals have been implicated, in more than 60 diseases including coronary and 
blood vessel diseases, cancers, cataracts, gastrointestinal diseases, and the aging 
process itself (Greenly, 2004). Thus the body‟s exposure to free radicals should be 
reduced, consequently reducing the risk or likelihood of many health problems. 
2.2.2.1 Free radical sources and types  
Free radicals are usually produced by the body itself as byproducts of 
metabolism. Heavy exercise can produce higher quantities of free radicals. Not only 
because that, many free radicals continually enter the body from exogenous sources 
such as air pollution. The examples are ozone, nitrous oxide, cigarette smoke 
through active or passive, drugs, pesticides, contaminated or rancid foods, 
unsaturated fats and exposure to ionizing radiation example ultraviolet light, X-rays 
and cosmic. There are four main types of destructive oxygen species. The hydroxyl 
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radicals (OH
-
), are the most highly reactive radicals, followed by superoxide radicals 
(O2·), oxygen that has gained one unpaired electron. Next is the oxygen singlet (
1
O2) 
which is a non-radical reactive oxygen species and finally hydrogen peroxide 
(H2O2), a non-radical reactive oxygen species (Greenly, 2004). 
2.2.2.2 Damaging effects of free radicals 
If the body is overwhelmed by excess free radicals, damages can occur to 
cell nuclei, cellular DNA, and the DNA repair process. This may cause uncontrolled 
cell growth that leads to malignant lesions and tumors. Excess free radicals also 
contribute to coronary atherosclerosis where low-density lipoprotein (LDL), the so-
called “bad cholesterol”, forms cholesteric plaques that accumulate when oxidized 
by free radicals. Macrophages attempting to eliminate the damaged LDL particles 
cannot drive out the cholesterol thus swell up to become foam cells. The building up 
of foam cells thicken the arterial walls consequently narrows the openings of the 
artery where it restricts the blood flow (Greenly, 2004).  
Oxidizing radicals also target cell membranes rich in polyunsaturated fatty 
acids (Cheesman and Slater, 1993). Specific enzymatic oxidation of polyunsaturated 
fatty acids leads to the formation of extremely potent and biologically important 
compounds such as prostaglandins and leukotrienes. In contrast, nonspecific 
oxidation of polyunsaturated fatty acids can lead to lipid peroxidation via a radical 
mediated pathway (Al-Omar et al., 2004) 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) react 
with practically all bio molecules, including DNA, RNA, proteins, carbohydrates 
and lipids, thus damaging the attacked molecule (Diplock et al., 1998). Oxidative 
damage caused by ROS and RNS will lead to DNA lesions (Spencer et al., 2000; 
Waris and Ahsan, 2006), function loss of enzymes (Sastre et al., 2000), increased 
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cell permeability (Yorimitsu et al., 2004; Kim et al., 2006), disturbed signaling over 
the cell and eventually even necrotic cell death or apoptosis (Shen and Liu, 2006). 
Consequently, damage induced by reactive species is often suggested to play a role 
in the patho-physiology of various diseases, including diabetes (Mehta et al., 2006) 
and cancer (Valko et al., 2006). Lung diseases such as chronic obstructive 
pulmonary disease (Boots et al., 2003), the interstitial lung diseases sarcoidosis 
(MacNee, 2001; Kanoh et al., 2005) and idiopathic pulmonary fibrosis are also the 
effects caused by free radicals (Rahman et al., 1999). Reactive oxygen species 
generated by mitochondria or from other sites within or outside the cell, cause 
damage to mitochondrial components and initiate degradative processes. Such toxic 
reactions contribute significantly to the aging process and form the central dogma of 
“The Free Radical Theory of Aging” (Enrique and Kelvin, 2000). 
 
 
2.3 Toxicological study 
 Toxicology derived from the Greek words of toxicos and logos. It means 
science that studies the adverse affects of chemical and biological substances for 
example heavy metals like cadmium, copper and lead. The study is performed to 
evaluate the effect of plant extracts on human, animal, or microbe. Toxicology is an 
inter-disciplinary science that integrates the principles and methods of many fields 
such as chemistry, biology, pharmacology, molecular biology, physiology and 
medicine (Sasidharan et al., 2008b). 
Toxicological study is essential in modern drug development to identify and 
isolate new compounds from natural resources such as plants. Validation and 
selection of primary toxicological screening methods are essential to guarantee the 
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selection of extracts or molecules with relevant pharmacological action and worth 
following-up. Primary toxicological screening methods are generally designed for 
rapid screening of large numbers of extracts with a potential biological activity. This 
method should be simple, precise and easy to be implemented. The results should be 
obtained quickly and the method use is preferably low in cost. 
2.3.1 Toxicity test 
Toxicity test procedures are composed of the following components; a 
biological system, an endpoint which refers to the processes responses or effects 
assessed and an endpoint measurement that refers to the techniques used to assess 
endpoints. It is also a data analysis method and a way of expressing the result, a 
prediction model for converting the test result into a prediction of toxicity in vivo, 
and a means of expressing toxic hazard where it is a quantitative prediction of the 
adverse effects of a chemical under defined conditions (Balls and Fentem, 1999).  
2.3.1.1 Brine shrimp lethality test 
The brine shrimp Artemia salina L. (Artemiidae) is an invertebrate 
component of the fauna of saline aquatic and marine ecosystems. It plays an 
important role in the energy flow of food chain (Sanchez-Fortun et al., 1995). 
Artemia salina are used in laboratory bioassays in order to determine toxicity by the 
estimation of the medium lethal concentration (LC50 values) (Lewan et al., 1992), 
which have been reported for a series of toxins and plant extracts (Meyer et al., 
1982). This method determines the LC50 value of the active compounds and extracts 
in saline medium in μg/mL (Massele and Nshimo, 1995). It has been implemented in 
research on medicinal plants carried out in different countries in order to evaluate 
toxicity, gastro-protective action, and other biological actions. In some cases, it has 
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also been related to pharmacological studies carried out for different chemical 
compounds (Mathews, 1995) where it acts as a screening method mainly for plant 
origin products (Parra et al., 2001). 
2.3.1.2 Oral acute toxicity test 
Acute toxicity standard tests are simple and a routine method where it can be 
conducted easily in laboratory basis. However, this test is strictly run in accordance 
to simple requirements, observing recommended condition and using indicated 
organisms. Acute toxicity test is aimed to determine the concentration of plant 
extracts which produces harmful effects on a group of test organisms such as mice in 
a short-term exposure under controlled condition. The most common acute toxicity 
test applied to animals is the acute lethality test (Sasidharan et al., 2008b). Lack of 
movements is normally recognized as criteria of death (Rand and Petrocelli, 1985). 
 Historically, the first toxicity test performed was the acute toxicity study 
(Casarett and Doull, 1999). The main objective of the study is to discover a single 
dose causing major unfavorable effects or life threatening toxicity. This often 
involves an estimation of the minimum dose causing lethality (Robinson et al., 
2008). Studies are usually carried out on rodents where it consists of a single dose 
up to a limit of 2000 mg/kg (OECD, 2001). In development of drug in 
pharmaceutical line, this is the only type of study where lethality or life-threatening 
toxicity is an endpoint as documented in current regulatory guidelines (CDER, 1996; 
ICH-Japan, 1999). 
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2.4 Candida 
 Candida is ubiquitous and more than 200 species have been studied and 
described (Armstrong, 1995).  Most Candida species are part of our microbiological 
flora and only 10% are responsible for infections towards human (Jarvis, 1995). The 
Candida genus characteristic is white asporogenous yeasts that are capable of 
forming pseudohyphae. Within this genus, species are characterized primarily based 
on colonial morphology, carbon utilization and fermentation. The most important 
and virulent which is frequently isolated species is the C. albicans (McCullough et 
al., 1996). 
2.4.1 Microbiological characteristics 
The colonies of Candida species, macroscopically are cream coloured to 
yellowish. Their texture may be pasty, smooth, glistening or dry, wrinkled and dull 
depending on the species. In the microscopic features, important species related 
variations are observed. All species produce blastoconidia which may be round or 
elongated. Most produces pseudohyphae that are long, branched or curved. In 
addition, true hyphae and chlamydospores are produced by some Candida strains 
which can be observed in Plate 2.1. The photograph shows the yeast and septate 
hyphae of C. albicans by Gram stain done on vaginal smear to observe the epithelial 
cell. Although all the members are from the same genus, the various species present 
a degree of unique behavior. This is with respect to their colony texture, microscopic 
morphology on cornmeal Tween 80 agar at 25°C (Dalmau method), and 
fermentation or assimilation profiles in biochemical tests that help to differentiate 
Candida from other yeasts (Freydiere et al., 2001). 
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Plate 2.1: Microscopic features of Candida species  
    (Adapted: Figure B, pg 686, Eggimann et al., 2003) 
 
 
 
2.4.2 Mechanisms of resistance 
There are several resistance mechanisms that have been seen in Candida 
species. Resistance often arises from different synergistic combinations of a limited 
number of molecular mechanisms. These include changes in the cell wall or plasma 
membrane leading to an impaired uptake of antifungals, efflux pumps that take 
antifungals outside the cell, overexpression of the antifungal targets and mutation of 
the antifungal target that decrease their binding ability (Bossche et al., 1998). Other 
resistant mechanisms are activation of alternate pathways that increases the 
metabolism of the antifungal, sequestration of the antifungal in organelle-like 
vacuoles and chromosomal changes to increase the number of copies of the required 
gene (Sanglard et al., 1997). The susceptibility of Candida species to antifungal 
agents is not uniform (Eggimann et al., 2003). 
 
 
19 
 
2.4.3 Virulence factors 
Candida species have the ability to produce virulence factors that enhance 
their capacity to colonies mucosal or synthetic surfaces (Brassart et al., 1991) and to 
invade host tissues by disrupting the host cell membranes. Proteinases and species-
specific phospolipases account for most secretory proteins acting as virulence 
factors in host cell and animal models of candidiasis (Ghannoum, 2002). The 
secreted aspartyl proteinases (SAP) and phospholipases (PL) are two rather large 
families of C. albicans enzymes, some of which have been associated with virulence 
(Calderone and Fonzi, 2001). The ability of Candida species to switch between 
different phenotypic forms in response to environmental conditions has been 
studied. Increased secretion of proteolytic enzymes and hyphae formation have been 
associated with the switching phenomena. C. albicans isolates from active infection 
have been reported to show a higher prevalence of phenotypic switching than those 
associated with commensalism (Eggiman et al., 2003). Moreover, some 
characteristics of azole resistance may be related to phenotyping switching 
(Sanglard and Odds, 2002). Freshly isolated strains from vaginitis or systemically 
infected patients have higher frequencies of switching (Eggiman et al., 2003). 
2.4.4 Candida albicans 
C. albicans is dimorphic yeast that is commonly isolated as a commensal 
microorganism from the human body. It is a very important and prevalent human 
fungal pathogen which is superficial as well as potentially life-threatening systemic 
mycoses. In tissues and in histological samples, the presence of hyphae, 
pseudohyphae and blastoconidia are known as pathogenic factors of C. albicans. 
Another important pathogenic factor is the production of germinative tubes (Drago 
et al., 2000). 
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C. albicans is a diploid microorganism (N=8) and genetic evidence suggests 
a primarily colonel mode of reproduction (Lott and Evat, 2001). However, there has 
been recent evidence for the manifestation of sexual cycle in C. albicans (Hull et al., 
2000). C. albicans is part of the normal microbial flora in human beings and 
domestic animals. It is associated with the mucous surfaces of the oral cavity, 
gastrointestinal tract and vagina. However, immune dysfunction can allow C. 
albicans to switch from a commensal to a pathogenic organism that is capable of 
infecting a variety of tissues and causing a possibly fatal systemic disease when 
there is immune dysfunction (Traynor and Huffnagle, 2001).  
Miller and Johnson (2002) challenge the concept that C. albicans mating is 
an artificial when they discovered a high efficiency mating in C. albicans in a 
laboratory engineered event. The super-mating opaque discovered cells indicates 
that C. albicans has maintained a specialized cell state for the purpose of sexual 
reproduction. The sexual cycle is an important part of the life cycle for most 
eukaryotes. One of the advantages of sexual reproduction is that it allows 
recombination between different genetic backgrounds to facilitate the spread of 
beneficial mutations into the population (Burt, 2000). Then again, recombination 
might help to eliminate deleterious mutations efficiently from the population (Zeyl 
and Bell, 1997). Either way, recombination is important enough to drive many 
organisms to invest energy in the processes of mating and meiosis. Studies of the 
population structures of C. albicans indicate that, while most genes are inherited 
clonally, some low-level recombination may be occurring (Anderson et al., 2001). 
This yeast possesses a large spectrum of hydrolytic enzymes with relatively broad 
substrate specificities including proteases, phospholipases and lipases, which might 
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be the reason for the outstanding position of this human pathogen (Stehr et al., 
2003). 
2.4.4.1 Formation of biofilm by Candida albicans 
In natural environment, microorganisms exist predominantly in biofilms 
which is the surface-attached communities of organisms. Although numerous 
definitions of a biofilm are introduced, the definition proposed by Donlan and 
Costerton (2002) is „mature  biofilm is a community of microorganisms irreversibly 
attached to a surface, containing exopolymeric matrix and exhibiting distinctive 
phenotypic properties‟. C. albicans causes infection in its biofilm mode of growth 
and has taken centre stages with the increasing recognition of its role in human 
infections due to the development of resistant or phenotic adaptation within the 
biofilm (Jain et al., 2007). C. albicans biofilms formed under static conditions where 
it contains small amounts of exopolymeric material (Hawser et al., 1998). 
 The overall organisation of C. albicans biofilm is generally similar to a 
bacterial biofilm but the details of C. albicans biofilm structure are highly dependent 
upon the conditions under which the biofilm formed (Chandra et al., 2001a). This 
plasticity in structure suggests that biofilms formed in the human host may also vary 
depending upon the nature of the implanted device and its location (Kumamoto, 
2002). The most important feature of biofilm growth is the high resistance to 
antimicrobial agents exhibited by organisms in a biofilm. The action of an antifungal 
is limited by their penetration and chemical reaction into biofilm matrix (Vishnu et 
al., 2008). The increasing resistant of C. albicans towards these antifungal 
compounds and the reduced number of available drugs led to the search of new 
therapeutic alternatives.  
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2.4.5 Diseases caused by Candida 
The C. albicans yeast is the most common cause of human fungal infections 
leading to candidiasis (Calderone and Fonzi, 2001; Calderone, 2002). The origin of 
invasive candidiasis is known as endogenous where from commensal yeasts of the 
gut or the skin, distributes influenced by a number of factors. Candidiasis is mainly 
observed in wards of at-risk patients. Nevertheless, colonization and subsequent 
infection can also be acquired during hospitalisation (Vazquez et al., 1998). This is 
clear by the occurrence of outbreaks, suggesting a common source of contamination, 
associated with either hand transmission or contaminated materials or infusions 
(Shin et al., 2000; Kuhn et al., 2004).  
It has been reported by Fidel (2002) that immune protection against 
candidiasis could be site specific emphasizing the complex nature of the disease.  
During the development of disease, the microorganism invades tissues by yeast-
hyphal transition. Direct infection of yeast cells by mucosal cells has also been 
observed (Calderone and Fonzi, 2001; Leigh et al., 2001). The oral mucosa is a 
highly specialized stratified epithelia that protects the body from physical and 
chemical damage, infection, dehydration and heat loss through interactions with the 
mesenchymal tissues (Nomanbhoy et al., 2002; Rouabhia et al., 2002; French and 
Pollitt, 2004). However, the mechanism by which Candida an innocuous oral 
commensal, may occasionally becomes pathogenic and induces oral lesions despite 
an intact immune surveillance system, remains unclear (Nomanbhoy et al., 2002; 
Rouabhia et al., 2002). 
Figure 2.1 shows the early events in the pathogenesis of candidiasis on a 
mucosal surface. The yeast cell of C. albicans is either at the budding or germinating 
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stage. On the mucosal surface the germination of yeast cells and penetration of the 
mucosa is shown. The persorption of yeast cells also results in the uptake of budding 
cells into the submucosa. On the far right, phagocytosis of yeast by a mucosal cell is 
pictured. These actions are facilitated by adhesins such as „Als1p, Als5p, Hwp1p 
and Int1p‟ and „Saps and Plb1p‟ enzymes (Calderon and Fonzi, 2001). Persorption 
and induced phagocytosis have been described by others (Enache et al., 1996). 
 
 
Figure 2.1: Early events in the pathogenesis of candidiasis portrayed on mucosal  
      surface (Adapted: Figure 1, pg 328, Calderon and Fonzi, 2001) 
 
2.4.5.1 Genital candidiasis 
In the USA, vaginal infection caused by a Candida is the second most 
common disease, after the bacterial vaginosis infection (Sobel, 2005). During the 
childbearing years, 75% of women experience at least one episode of vulvovaginal 
candidiasis, and 40-50% of these women experience a second attack. From this a 
small subpopulation of women suffers repeated recurrent episodes of Candida 
vaginitis. Candida gains access to the vaginal lumen and secretions predominantly 
from the adjacent perianal area, and then adheres to vaginal epithelial cells. The 
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numbers of C. albicans that adhere to the vaginal epithelial cells are significantly 
greater than Candida tropicalis, Candida krusei and Candida glabrata. As for mens, 
two forms of balanoposthitis or balanitis are associated with the Candida species 
where both are obtained sexually. A true superficial but invasive infection occurs 
particularly in uncircumcised males and those with diabetes. It is characterized by 
intense pruritus, discomfort, erythema and swelling that are localized primarily to 
the glans, but may extend to involve the penile shaft and scrotum (Sobel, 2005). 
2.4.5.2 Inflammatory lesions in muscular and soft tissues 
Once C. albicans gains access to the bloodstream, it can cause lesions in 
several organs and tissues, including muscle. There are cases where myocarditis and 
skeletal muscle infections been reported in patients with disseminated candidiasis 
(Odds, 1988). Furthermore, muscle infections induced by C. albicans have been 
described in experimental animal models for characterizing immune response to 
fungal infections (Ruiz-Cabello et al., 1999). 
2.4.5.3 Fungal infection in leukemia patient 
The incidence of fungal infection in acute leukemia is increasing (Jarvis, 
1995). The reasons for this trend are, the increasing intensity of chemotherapy due to 
new aggressive cytotoxic protocols causing profound and long lasting neutropenia, 
mucositis (Morrison, 1994). Bone marrow transplantation with multifactorial 
immunosuppression, prolonged survival in previously rapidly fatal neoplasias, broad 
spectrum antimicrobial therapy or prophylaxis, prolonged stays in hospitals and 
extensive use of vascular catheters are the other factors (Jarvis, 1995). 
2.4.5.4 Lung infection 
            In hospitalised patients, Candida species are also frequent colonizers of the 
respiratory tract. True Candida pneumonia is extremely rare and only ever occurs in 
